# Dalan Animal Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dalan-animal-health

- Industry: Biotechnology
- Headquarters: Athens, US
- Website: www.dalan.com
- Total disclosed funding: $11M
- Latest round: Seed (Nov 19, 2025)
- Investors on record: 5

## About

Dalan Animal Health, Inc. is a bioscience company dedicated to innovative vaccine development, focusing on protecting honeybees and shrimp from critical diseases. Their solutions address significant agricultural challenges related to pollinator health and aquaculture sustainability.Dalan Animal Health, Inc. was founded in 2019 and is headquartered in Athens, US. The company specializes in developing vaccines for honeybees and shrimp, including a USDA approved honeybee vaccine and a shrimp vaccine targeting significant diseases. In November 2025, Dalan Animal Health, Inc. raised USD 3 million in seed funding from Meach Cove Capital and Good Growth Capital. As of January 2026, the company is led by its CEO Annette Kleiser.Dalan Biosciences specializes in the development of innovative bioscience solutions, focusing on vaccines that protect against critical diseases affecting honeybees and shrimp. Their flagship product, a USDA approved honeybee vaccine, addresses major honeybee diseases, while they are also developing a shrimp vaccine against the White Spot Syndrome Virus (WSSV) and Early Mortality Syndrome (EMS). The company markets its products primarily to beekeepers, aquaculture firms, and agricultural businesses, with a commitment to enhancing food production sustainability across global markets, including North America, Europe, and select regions in Asia.Dalan Biosciences operates on a transaction model that includes direct sales to commercial beekeepers and aquaculture producers, as well as partnerships with agricultural distributors. Revenue is generated through the sale of proprietary vaccines, offered via one-time purchases or multi-year agreements to ensure product availability. Pricing plans for the honeybee and shrimp vaccines are tailored based on volume and customer requirements, ensuring competitive positioning within the bioscience industry. In November 2025, Dalan Animal Health, Inc. raised USD 3 million in seed funding to advance commercialization of its shrimp vaccine and expand platform applications to new species.

## Funding rounds

- Seed, Nov 19, 2025, $3M — Good Growth Capital, Meach Cove Capital
- Seed, Feb 1, 2023, $4.5M — Prime Movers Lab, At One Ventures
- Seed, Aug 26, 2022, $3.5M — At One Ventures, Veterinary Angel Network

## Investors

- At One Ventures (https://capitalatlas.ai/funds/at-one-ventures) — Seed
- Veterinary Angel Network — Seed
- Prime Movers Lab (https://capitalatlas.ai/funds/prime-movers-lab) — Seed
- Good Growth Capital (https://capitalatlas.ai/funds/good-growth-capital) — Seed
- Meach Cove Capital (https://capitalatlas.ai/funds/meach-cove-capital) — Seed